CGM for Management of Type 2 Diabetes in Pregnancy | MicrobiomeTrials← Back to trialsNCT06628453
CGM for Management of Type 2 Diabetes in Pregnancy
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-04-08Est. Completion: 2029-02
Enrollment target: 564 participants Locations- University of Alabama at Birmingham, Birmingham, Alabama, United States
- University of California at San Diego, San Diego, California, United States
- University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
- Oregon Health and Science University, Portland, Oregon, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- Prisma Health Greenville Memorial Hospital, Greenville, South Carolina, United States
- University of Texas Health Science Center at Houston, Houston, Texas, United States
Other microbiome trials you might be interested in
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disease, often compounded by obesity, that leads to serious l…
Multiple LocationsEst. completion Jan 12, 2027
Non-alcoholic Fatty Liver Disease
The purpose of this study is to assess the safety and efficacy of efimosfermin alfa in the resolution of steatohepatitis…
Chandler, United StatesEst. completion Mar 29, 2028
Recruiting
Type 2 Diabetes Mellitus (T2DM)Obesity (Disorder)OverweightMetabolic Syndrome
The goal of this clinical trial is to learn whether the NutriSteppe mobile application can improve blood sugar control a…
Almaty, KazakhstanEst. completion Nov 2026